CARE Ratings (BOM:534804) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:534804 CARE Ratings Ltd BOM:534804
81 GF Score
Price ₹1,746.10
GF Value ₹1,709.11
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is CARE Ratings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


CARE Ratings Valuation Rank Related Terms

BOM:534804
81GF Score
CARE Ratings Ltd BOM:534804
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is CARE Ratings (BOM:534804) Overvalued in 2026?

Based on GuruFocus' analysis, CARE Ratings stock appears to be overvalued. The current stock price of ₹1,746.10 is trading 2.2% above its estimated GF Value™ of ₹1,709.11. GuruFocus considers CARE Ratings to be Fairly Valued.

Key valuation signals for BOM:534804:

  • Valuation Rank:
  • GF Value™: ₹1,709.11 vs. price of ₹1,746.10 (2.2% above fair value)
  • GF Score™: 81/100 with 1 warning sign

No single metric tells the full story. See the BOM:534804 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CARE Ratings Business Description

Other Exchanges CARERATING:India
Address Somaiya Hospital Road, Off Eastern Express Highway, 4th Floor, Godrej Coliseum, Sion (East), Mumbai, MH, IND, 400 022
CARE Ratings Ltd provides various credit ratings that helps corporates to raise capital for their various requirements and assists the investors to form an informed investment decision based on the credit risk and their own risk-return expectations. The company works in Bank Loan Ratings; Capital Market Instruments, Including NCDs/ Bonds/ Hybrids/ CPs/CDs, etc; Structured Finance Ratings; Monitoring Agency Services for Equity Capital; Rating of REITs /InvITs; Resolution Plan Ratings; Recovery Ratings; Issuer Ratings. The company's segment includes Ratings and related services; and Others. The company generates majority of revenue from Ratings and related services. The company has presence in India, and Outside India. It generates majority of revenue from India.
81GF Score

Get the complete analysis for BOM:534804

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,746.10
Price
₹1,709.11
GF Value